Anti-NMDA receptor encephalitis presenting as new onset refractory status epilepticus in COVID-19
Anti-NMDA receptor encephalitis presenting as new onset refractory status epilepticus in COVID-19
复制标题
DOI：
10.1016/j.seizure.2020.07.006
复制
发表时间：
2020-10-01
影响因子：
3
通讯作者：
Meletti, Stefano
中科院分区：
文献类型：
--
作者：
Monti, Giulia;Giovannini, Giada;Meletti, Stefano
COVID-19的自身免疫性脑炎和癫痫持续状态可能具有挑战性。免疫治疗可能有助于抗NMDAr脑炎和SARS-Cov-2感染。细胞因子风暴可能在NMDA-R脑炎的NORSE表现中发挥作用。
HighlightsAutoimmune encephalitis and status epilepticus in COVID-19 can be challenging.Immunotherapy could be useful for anti-NMDAr encephalitis and SARS-Cov-2 infection.Cytokines storm could play a role for NORSE presentation in NDMA-R encephalitis.